A2AR PAM program (Addex)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameA2AR PAM program (Addex)
Drug Alias Nameadenosine 2 receptor agonists (Addex)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2 receptor agonists
TargetsAdenosine A2 receptor
Therapy Area/IndicationsPsoriasisOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAddex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAddex Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsPsoriasisOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A